329 related articles for article (PubMed ID: 34958107)
1. Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes (Review).
Votavova H; Belickova M
Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34958107
[TBL] [Abstract][Full Text] [Related]
2. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.
Matsui WH; Brodsky RA; Smith BD; Borowitz MJ; Jones RJ
Leukemia; 2006 Mar; 20(3):458-62. PubMed ID: 16437138
[TBL] [Abstract][Full Text] [Related]
4. Hypoplastic form of myelodysplastic neoplasm.
Votavová H; Lenertová Z; Votava T; Beličková M
Klin Onkol; 2023; 36(3):206-214. PubMed ID: 37353349
[TBL] [Abstract][Full Text] [Related]
5. Immunological derangement in hypocellular myelodysplastic syndromes.
Serio B; Risitano A; Giudice V; Montuori N; Selleri C
Transl Med UniSa; 2014 Jan; 8():31-42. PubMed ID: 24778996
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
Barrett J; Saunthararajah Y; Molldrem J
Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
[TBL] [Abstract][Full Text] [Related]
7. Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?
Fattizzo B; Serpenti F; Barcellini W; Caprioli C
Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33401595
[No Abstract] [Full Text] [Related]
8. [Clinical significance of clonal hematopoiesis and disease boundaries in bone marrow failure diseases].
Suzuki T
Rinsho Ketsueki; 2023; 64(6):474-481. PubMed ID: 37407470
[TBL] [Abstract][Full Text] [Related]
9. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
10. Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome.
Karantanos T; DeZern AE
Best Pract Res Clin Haematol; 2021 Jun; 34(2):101280. PubMed ID: 34404534
[TBL] [Abstract][Full Text] [Related]
11. MDS overlap disorders and diagnostic boundaries.
Tanaka TN; Bejar R
Blood; 2019 Mar; 133(10):1086-1095. PubMed ID: 30670443
[TBL] [Abstract][Full Text] [Related]
12. CD34 and p53 immunohistochemical stains differentiate hypocellular myelodysplastic syndrome (hMDS) from aplastic anemia and a CD34 immunohistochemical stain provides useful survival information for hMDS.
Cha CH; Park CJ; Chi HS; Seo EJ; Jang S; Cho YU; Lee KH; Lee JH; Lee JH; Im HJ; Seo JJ
Ann Lab Med; 2014 Nov; 34(6):426-32. PubMed ID: 25368817
[TBL] [Abstract][Full Text] [Related]
13. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.
Becktell K; Berlyne D; Pagliuca S; Pommert L; Prata PH; Margolis D; de Latour RP; Dufour C; Pierri F
Leuk Res; 2019 May; 80():19-25. PubMed ID: 30908982
[TBL] [Abstract][Full Text] [Related]
14. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
[TBL] [Abstract][Full Text] [Related]
15. Aplastic anemia: Pathophysiology.
Giudice V; Selleri C
Semin Hematol; 2022 Jan; 59(1):13-20. PubMed ID: 35491054
[TBL] [Abstract][Full Text] [Related]
16. Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation.
Durrani J; Groarke EM
Semin Hematol; 2022 Jul; 59(3):137-142. PubMed ID: 36115690
[TBL] [Abstract][Full Text] [Related]
17. The relationship between idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and autoimmunity.
Barcellini W
Expert Rev Hematol; 2017 Jul; 10(7):649-657. PubMed ID: 28586251
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing in hypoplastic bone marrow failure: What difference does it make?
Skibenes ST; Clausen I; Raaschou-Jensen K
Eur J Haematol; 2021 Jan; 106(1):3-13. PubMed ID: 32888355
[TBL] [Abstract][Full Text] [Related]
19. Early Detection of Myelodysplastic Syndrome/Leukemia-associated Mutations Using NGS Is Critical in Treating Aplastic Anemia.
Li X; Wu YH; Cai SS; Li WM; You Y; Zhang M
Curr Med Sci; 2019 Apr; 39(2):217-221. PubMed ID: 31016513
[TBL] [Abstract][Full Text] [Related]
20. When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms.
Zhao XC; Ju B; Xiu NN; Sun XY; Meng FJ
Front Immunol; 2024; 15():1339971. PubMed ID: 38426096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
